As part of its commitment to expanding its presence in Hungary, global animal vaccine producer Ceva-Phylaxia has announced an EUR 75 million investment, establishing a state-of-the-art unit in Monor dedicated to manufacturing inactivated, multicomponent vaccines, the Hungarian Investment Promotion Agency (HIPA) reports. Following the official groundbreaking ceremony for the 7,000-square-meter facility, production is expected to […]